Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Greenwich LifeSciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 24 | 27 | +3 |
| Shares | 537.4K | 536.0K | −1.40K (−0.3%) |
| Value | $4.75M | $5.64M | +$888.2K (+18.7%) |
New holders (6)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 20,983 | $220.7K | 0.00% |
| 683 Capital Management, LLC | 19,604 | $206.2K | 0.02% |
| Jane Street Group, LLC | 14,005 | $147.3K | 0.00% |
| Citigroup Inc | 9,524 | $100.2K | 0.00% |
| Game Plan Financial Advisors, LLC | 200 | $2.10K | 0.00% |
| Washington Trust Advisors, Inc. | 200 | $2.10K | 0.00% |
Sold out (3)
Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 45,850 | $405.0K |
| Squarepoint Ops LLC | 10,970 | $97.0K |
| Advisor Group Holdings, Inc. | 50 | $442 |